During the past decade, Rex Hematology Oncology Associates-Blue Ridge conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rex Hematology Oncology Associates-Blue Ridge" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 4 trials, followed by "SWOG Cancer Research Network" with 4 trials sponsored, "NRG Oncology" with 2 trials sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rex Hematology Oncology Associates-Blue Ridge" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Rex Hematology Oncology Associates-Blue Ridge" are "Anatomic Stage II Breast Cancer AJCC v8" (2 trials), "Anatomic Stage IIA Breast Cancer AJCC v8" (2 trials), "Anatomic Stage IIB Breast Cancer AJCC v8" (2 trials), "Anatomic Stage IIIA Breast Cancer AJCC v8" (2 trials) and "Invasive Breast Carcinoma" (2 trials). Many other conditions were trialed in "Rex Hematology Oncology Associates-Blue Ridge" in a lesser frequency.

Most popular intervention types in "Rex Hematology Oncology Associates-Blue Ridge" are "Drug" (9 trials), "Other" (7 trials), "Biological" (4 trials), "Procedure" (4 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (2 trials), "Paclitaxel" (2 trials), "Patient Observation" (2 trials), "Quality-of-Life Assessment" (2 trials) and "Questionnaire Administration" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rex Hematology Oncology Associates-Blue Ridge" are 11 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Rex Hematology Oncology Associates-Blue Ridge". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Rex Hematology Oncology Associates-Blue Ridge, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Rex Hematology Oncology Associates-Blue Ridge, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".